Purchases and Sales Made in Q2 2023 in Nls Pharmaceutics Ltd. (NLSP)
This table provides information about the institutional ownership of Nls Pharmaceutics Ltd. (NLSP) during Q2 2023. The information is specifically focused on institutions that hold shares of NLS Pharmaceutics Ltd..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
Affinity Asset Advisors, LLC
New York, NY |
BUY
|
- |
55.9K+ 16.25% |
$51.4K - $87.2K
|
400K
$756K
|
|
|
Aug 14, 2023
Q2 2023
|
Two Sigma Securities, LLC
New York, NY |
BUY
|
- |
37.1KNew |
$34.1K - $57.9K
|
37.1K
$70.1K
|
|
|
Aug 11, 2023
Q2 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
22.6K+ 70.4% |
$20.8K - $35.3K
|
54.7K
$103K
|
|
|
Aug 11, 2023
Q2 2023
|
Ubs Group Ag
|
BUY
|
- |
3.41KNew |
$3.13K - $5.31K
|
3.41K
$6.44K
|
|
|
Aug 14, 2023
Q2 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
100New |
$92 - $156
|
100
$189
|
|
|
Aug 10, 2023
Q2 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 14, 2023
Q2 2023
|
J. Goldman & CO LP
New York, NY |
SELL
|
- |
-416- 0.2% |
$383 - $649
|
204K
$386K
|